AIMx Podiatry LLC, a pioneer in biologic and regenerativepodiatric solutions, has announced the appointment of Dr. Thuy Ho-Ellsworth, DPM, as its new Chief Medical Officer. Dr. Ho-Ellsworth is the founder and owner of Align Foot & Ankle in Austin, Texas, and brings a wealth of experience in biologic medicine and minimally invasive foot and ankle surgery to support AIMx's mission of reshaping the future of podiatric care.
https://mma.prnewswire.com/media/2736382/AIMx_Podiatry_Logo.jpg
AIMx is dedicated to supporting progressive podiatrists with innovative therapies that enhance patient outcomes and practice sustainability. The company offers a suite of advanced, cash-based solutions including Liposana®, a complete fat restoration treatment for the foot, DPMx umbilical cord allografts, and medical-grade peptides-an emerging area of focus within podiatry. These biologic tools are designed to promote tissue healing, improve mobility, and empower providers to offer next-level care without relying on traditional insurance frameworks.
Dr. Ho-Ellsworth is board-certified in Foot and Reconstructive Rearfoot and Ankle Surgery by the American Board of Foot and Ankle Surgery. She is also a Fellow of the Academy of Minimally Invasive Foot and Ankle Surgery and an Associate Instructor of Minimally Invasive Surgery with the American College of Podiatric Physicians and Surgeons. With more than 14 years of experience serving the Austin community, she launched Align Foot & Ankle in 2022 to focus on patient-centered care, regenerative therapies, and minimally invasive surgical solutions.
Known for her mantra of “changing the algorithm,” Dr. Ho-Ellsworth is passionate about implementing data-driven, personalized care that challenges outdated protocols and raises the standard of treatment across the profession. Her leadership has helped usher in a new era of podiatry that embraces efficiency, innovation, and long-term wellness.
“We're honored to welcome Dr. Thuy Ho-Ellsworth to the AIMx team as our Chief Medical Officer,” said John Zagurasky, President of AIMx Podiatry. “Her visionary approach and deep expertise in biologics are exactly what today's podiatrists need to thrive in a changing landscape. She brings not only clinical excellence but also a commitment to education, mentorship, and meaningful change.”
In her new role, Dr. Ho-Ellsworth will lead clinical strategy, oversee product development, and spearhead educational initiatives aimed at supporting forward-thinking podiatrists across the country.
To learn more about AIMx Podiatry and its solutions, visitaimxpodiatry.com or e-mail partner@aimxpodiatry.com
About AIMx Podiatry LLC
AIMx Podiatry LLC equips ambitious podiatrists with innovative biologics, medical technologies, peptides, and compliant cash-pay therapies. By focusing on tissue repair, patient outcomes, and sustainable practice growth, AIMx helps providers elevate care and succeed outside of traditional insurance models.
PR contact:
AIMx Podiatry, LLCJohn ZaguraskyP: 512-829-8221partner@aimxpodiatry.com
https://c212.net/c/img/favicon.png?sn=DA35689&sd=2025-07-23
View original content to download multimedia:https://www.prnewswire.com/news-releases/aimx-podiatry-llc-names-dr-thuy-ho-ellsworth-as-chief-medical-officer-to-lead-innovation-in-podiatric-care-302511352.html
SOURCE AIMx Podiatry
https://rt.newswire.ca/rt.gif?NewsItemId=DA35689&Transmission_Id=202507231005PR_NEWS_USPR_____DA35689&DateId=20250723